Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Coordination and Support Action · Finished

COBIOE Growing Connection for Bio Ecosystems

Coordinator
Genopole Gip, France
Runs
1 March 2023 to 30 June 2025
Status
Finished
EU funding
€500k
Total cost
—
Partners
6 organisations in 4 countries
Type
Coordination and Support Action
Grant agreement
101095912

What the project is doing

In the project's own words, from its summary on CORDIS.

COBIOE is project to interconnect innovation ecosystems to foster 4.0 industrial transition in the biopharmaceutical deeptech sector, sharing competences, information and opportunities, with the aim of ultimately converging toward a common and inclusive European strategy for bioproduction support. Specifically, the proposition will focus on the bioproduction sector that includes development of small molecules, biologics, drugs, innovative therapeutics (such as gene and cellular therapies), high technology drugs based on cell and molecular biology, and covers various applications in health (oncology, immunology, virology, rare diseases, etc…).

COBIOE will reach the following objectives:- Provide a state of the art and exploitable overview of the European bioproduction value chain, focusing on European, national, regional strategy or existing initiatives, activities- Opening up the bioproduction field, by reaching out to isolated actors and territories bringing added value to the chain.- Building up bridges between sparse innovative ecosystems and initiatives opening up opportunities for isolated players.- Promote bioproduction ecosystems, the field and its potentialities in terms of green, digital and social transition, among various stakeholders and policymakersCOBIOE proposal includes 5 health clusters/networks, preeminent and pioneers in the field of pharmaceutical biomanufacturing.

Each partner complements each other in terms of competence and the partnership covers almost all European regions from north to south and east to west, including modest, moderate, strong and leading innovators. Moreover, each partner benefits from an extended network of stakeholders, from different technological sectors (materials science, artificial intelligence, biotechnology, blockchain, robotics, photonics, electronics and quantum information) and actors (universities, research, hospitals, funders…).

Topics

Who is involved

OrganisationCityCountryRole
Genopole GipEvryFranceCoordinator
Council of European BioregionsBruxelles / BrusselBelgiumParticipant
Scanbalt MtuTartuEstoniaParticipant
Eit Health Clc FranceParisFranceParticipant
Eit Health Hub FranceParisFranceParticipant
Health Cluster Portugal - Associacao do Polo de Competitividade da SaudeLeca Do BalioPortugalParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI